Syndax Pharmaceuticals Inc (SNDX): Eigentümerstruktur
| Analysten Konsens | Buy | Outperform | Hold | Underperform | Sell |
| 37,273 US Dollar | 10 | 2 | 0 | 0 | 0 |
| #Shares | Short [%] | Short Ratio |
| 88.610.027 | 20,51 | 8,03 |
Eigentümerstruktur
Analyse der Aktionärsstruktur und institutionellen Investoren
Unternehmensdaten
Grundlegende Informationen
Grunddaten
Name Syndax Pharmaceuticals Inc
Mitarbeiter 298
Handelsplatz NASDAQ
Ticker Symbol SNDX
IPO Datum 2016-03-03
Adresse 730 Third Avenue, New York, NY, United States, 10017
Webseite https://syndax.com
Unternehmensführung
| Rang | Name | Position |
|---|---|---|
| 1 | Mr. Michael A. Metzger M.B.A. | CEO & Director |
| 2 | Mr. Keith Alan Goldan CPA | CFO, Treasurer & Principal Accounting Officer |
| 3 | Mr. Luke J. Albrecht J.D. | General Counsel & Corporate Secretary |
| 4 | Mr. Steven Closter | Chief Commercial Officer |
| 5 | Dr. Nicholas A.J. Botwood B.Sc., MBBS | Head of Research & Development and Chief Medical Officer |
| 6 | Dr. Peter Ordentlich B.Sc., Ph.D. | Co-Founder & Chief Scientific Officer |
| 7 | Dr. Richard A. Heyman Ph.D. | Co-Founder |
| 8 | Dr. Michael Downes Ph.D. | Co-Founder |
| 9 | Sharon Klahre | Vice President of Investor Relations & Communications |
| 10 | Ms. Averi Price | Senior VP of Legal & Chief Compliance Officer |
Aktionärsverteilung
Aufteilung der Investoren
Größte Investoren
| Rang | Inhaber | Anteile | Wert |
|---|---|---|---|
| 1 | BlackRock Inc | 10,10% | 0,13 Mrd. USD |
| 2 | Kynam Capital Management, LP | 9,02% | 0,11 Mrd. USD |
| 3 | The Goldman Sachs Group Inc | 6,56% | 0,08 Mrd. USD |
| 4 | State Street Corp | 6,34% | 0,08 Mrd. USD |
| 5 | Bank of America Corp | 4,53% | 0,06 Mrd. USD |
| 6 | Vanguard Capital Management, LLC | 4,40% | 0,06 Mrd. USD |
| 7 | Deerfield Management Co | 4,23% | 0,05 Mrd. USD |
| 8 | Eversept Partners, LP | 3,13% | 0,04 Mrd. USD |
| 9 | Geode Capital Management, LLC | 2,89% | 0,04 Mrd. USD |
| 10 | Hood River Capital Management LLC | 2,87% | 0,04 Mrd. USD |
| 11 | Kingdon Capital Management LLC | 2,80% | 0,04 Mrd. USD |
| 12 | Franklin Templeton Inc | 2,56% | 0,03 Mrd. USD |
| 13 | Millennium Management LLC | 2,30% | 0,03 Mrd. USD |
| 14 | Vanguard Portfolio Management, LLC | 2,15% | 0,03 Mrd. USD |
| 15 | UBS Group AG | 2,12% | 0,03 Mrd. USD |
| 16 | Elmind Capital LP | 2,08% | 0,03 Mrd. USD |
| 17 | BNP Paribas Investment Partners SA | 2,00% | 0,03 Mrd. USD |
| 18 | Candriam Luxembourg S.C.A. | 1,90% | 0,02 Mrd. USD |
| 19 | Soleus Capital Management, L.P. | 1,82% | 0,02 Mrd. USD |
| 20 | Two Sigma Investments LLC | 1,77% | 0,02 Mrd. USD |